Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saint Luke's Health System is a premier non-profit healthcare network based in Kansas City, Missouri, serving a 67-county region across Missouri and Kansas. The system operates 10 hospitals, including its flagship Saint Luke's Hospital of Kansas City, and is internationally recognized for its specialized research institutes such as the Saint Luke's Mid America Heart Institute and the Saint Luke's Marion Bloch Neuroscience Institute. In January 2024, Saint Luke's merged with BJC HealthCare to form BJC Health System, creating one of the largest integrated healthcare delivery networks in the United States with approximately $10 billion in annual revenue. As a primary teaching affiliate for the University of Missouri-Kansas City School of Medicine, the system is a major hub for clinical research, participating in hundreds of Phase 1-4 clinical trials in partnership with global pharmaceutical and biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St. Luke's Hospital System.